a
Company
HOME
ABOUT US
HOW TO SUBSCRIBE
REQUEST LISTING
MENU
HOME
ABOUT US
HOW TO SUBSCRIBE
REQUEST LISTING
CURRENT NEWS
22.12.2018
KAGOCEL - # 1 Among Domestic Brands, According to DSM Group
22.12.2018
Sale of Non Core Assets
21.12.2018
Navamedic ASA: Initiates Process for Acquiring Novicus Pharma
21.12.2018
Pulmatrix and Vectura Terminated Agreement on PUR0200
21.12.2018
Success of the €4 Million Capital Increase
21.12.2018
Biomax Informatics Launches Version 6.2 of Their Flagship Product, the BioXM Knowledge Management Environment
21.12.2018
Xemed LLC in Collaboration with Washington University at St. Louis Completes Clinical Study and Unblinds the Data
21.12.2018
EPICS Therapeutics to Acquire Ogeda Former Assets, Adding Drug Discovery & Development Capabilities
21.12.2018
FSD Pharma Responds to Therapix Termination of Binding LOI
21.12.2018
DKSH Signs Agreement to Acquire the Distribution Business of Auric Pacific in Singapore and Malaysia
21.12.2018
Promising Development; Research into More Focused Irradiation
21.12.2018
SCAD, Inc. Receives Approval for the Development of Products and Services Derived from Human Blood and Related Cells
21.12.2018
Cosmo Pharmaceuticals Methylene Blue MMX Regulatory Update: New Appeal Filing – Next Steps
21.12.2018
Eurofarma Launches Innovative Drug to Fight Obesity in Brazil and Other 17 Countries
21.12.2018
Applied DNA Announces Pricing of $2.75 Million Offering of Common Stock and Warrants
21.12.2018
Abattis Provides Marketing and Operational Updates
21.12.2018
Recordati: Expectations for 2018 Confirmed and 2019 Objectives Announced; Approval of the Issuer’s Notice Pursuant to Art. 103 Para. 3 of Italian Legislative Decree 58/1998, with Reference to the Public Mandatory Tender Offer for the Total Number of Ordinary Shares of Recordati S.P.A
21.12.2018
Exemplar Genetics and Mayo Clinic Launch Joint Venture Focused on Development of Human Liver Cells to Advance Medical Research
21.12.2018
Started Support Services for Specified Clinical Research Assuring the Quality of Research Support Through a Unique Certification System
21.12.2018
Aurobindo Pharma Receives USFDA Approval for Potassium Chloride ER Tablets
Records per page:
Page
Total:
15031
records.
×
How to see the list